ProQR Therapeutics N.V. (NASDAQ: PRQR)
$2.4100
-0.2100 ( -6.95% ) 149.7K
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
Market Data
Open
$2.4100
Previous close
$2.6200
Volume
149.7K
Market cap
$261.59M
Day range
$2.4160 - $2.7800
52 week range
$1.6100 - $4.6200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k/a | Form 6-K | 1 | Dec 12, 2024 |
| 6-k | Form 6-K | 2 | Dec 11, 2024 |
| 6-k | Form 6-K | 80 | Dec 11, 2024 |
| 6-k | Form 6-K | 2 | Dec 10, 2024 |
| 6-k | Form 6-K | 2 | Dec 05, 2024 |
| 6-k | Form 6-K | 70 | Nov 07, 2024 |
| 6-k | Form 6-K | 6 | Oct 25, 2024 |
| 6-k | Form 6-K | 70 | Aug 08, 2024 |
| 6-k | Form 6-K | 1 | May 22, 2024 |
| 6-k | Form 6-K | 72 | May 09, 2024 |